Genefirst have developed a COVID-19 test
We have developed a simple to use COVID-19 molecular diagnostic test which can be used in clinical laboratories to process patient samples and to detect those positive for COVID-19.
We have since extended this development to include other common flu season pathogens, such as Influenza and RSV in our test, to support effective screening and triage of symptomatic patients. With the support of our network across Europe we will be conducting clinical studies to determine the utility and effectiveness of adopting these assays into the healthcare system, such as the NHS. Whilst COVID development is a top priority, GeneFirst continues to develop and launch oncology tests for use with liquid biopsies, and to grow the team as part of the business plan for expansion. - Winnie Wu, CEO GeneFirst Limited
More Case Studies
Head to Head: Wendy Tindsley, Innovation Director for Oxford Innovation
We sat down with Innovation Director, Wendy Tindsley to find out a bit more about her and how she is looking forward to helping businesses across Oxfordshire and at Culham Innovation Centre.
Customer Story – Plasmatreat UK
We spoke to Ray Potgeiter, about how Plasmatreat got started, what they are currently working on, and how they are finding Culham Innovation Centre so far.
Customer Story – GeneFirst
We spoke to Winnie Wu, Chief Operations Officer about how GeneFirst got started, what they are currently working on, and how they are finding Culham Innovation Centre so far.